文献速递呼吸道感染

心血管并发症是SARS-CoV-2社区获得性肺炎住院患者死亡的主要驱动因素

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
PubMed 文献 · Chest · 2022-11-19

这项 cohort 研究纳入1645例SARS-CoV-2社区获得性肺炎(CAP)住院患者,采用四状态多状态模型与Cox比例风险回归分析。18%的患者发生心血管并发症,该组死亡率为45%,无心血管并发症组为13%。既往合并症、高龄、男性、病情严重度及低氧血症与心血管并发症风险升高相关,而一旦发生心血管并发症,死亡风险极高。

要点

  • 18%的SARS-CoV-2 CAP住院患者发生心血管并发症,该组死亡率45%,显著高于无并发症组的13%。
  • 男性、高龄、心衰、冠心病、房颤、直接入住ICU及Pao2/Fio2<200与心血管并发症风险升高相关。
  • 上述因素与发生心血管并发症后的死亡风险增加无关,提示并发症本身是死亡的主要驱动因素。

核心结论

  • 心血管并发症是SARS-CoV-2 CAP住院患者死亡的主要驱动因素,一旦发生则死亡风险极高。

研究设计与样本

  • 队列研究,纳入1645例SARS-CoV-2 CAP住院患者,采用四状态多状态模型描述住院临床过程,并用Cox比例风险回归分析既往合并症对状态转换的影响。

主要发现

  • 18%的SARS-CoV-2 CAP住院患者发生心血管并发症。
  • 发生心血管并发症组死亡率为45%,无心血管并发症组为13%。
  • 男性(HR,1.32;95%CI,1.03-1.68)、高龄(HR,1.34;95%CI,1.03-1.75)、充血性心力衰竭(HR,1.59;95%CI,1.18-2.15)、冠心病(HR,1.34;95%CI,1.00-1.79)、心房颤动(HR,1.43;95%CI,1.06-1.95)、直接入住ICU(HR,1.77;95%CI,1.36-2.32)及Pao2/Fio2<200(HR,1.46;95%CI,1.11-1.92)更易发生心血管并发症。
  • 上述因素与发生心血管并发症后死亡风险增加无关。

关键数值与推荐

  • 心血管并发症发生率18%,发生组死亡率45% vs 无并发症组13%。
  • 男性HR 1.32(95%CI 1.03-1.68);高龄HR 1.34(95%CI 1.03-1.75)。
  • 充血性心力衰竭HR 1.59(95%CI 1.18-2.15);冠心病HR 1.34(95%CI 1.00-1.79);心房颤动HR 1.43(95%CI 1.06-1.95)。
  • 直接入住ICU HR 1.77(95%CI 1.36-2.32);Pao2/Fio2<200 HR 1.46(95%CI 1.11-1.92)。

临床怎么用

  • 对SARS-CoV-2 CAP住院患者应评估心血管并发症风险,尤其关注男性、高龄、心衰、冠心病、房颤、直接入住ICU及Pao2/Fio2<200者。
  • 一旦发生心血管并发症,提示死亡风险极高,需加强监测与干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hospitalized patients with SARS-CoV-2 community-acquired pneumonia (CAP) and associated comorbidities are at increased risk of cardiovascular complications. The magnitude of effect of cardiovascular complications and the role of prior comorbidities on clinical outcomes are not well defined. RESEARCH QUESTION: What is the impact of cardiovascular complications on mortality in hospitalized patients with SARS-CoV-2 CAP? What is the impact of comorbidities and other risk factors on the risk of developing cardiovascular complications and mortality in these patients? STUDY DESIGN AND METHODS: This cohort study included 1,645 hospitalized patients with SARS-CoV-2 CAP. Cardiovascular complications were evaluated. The clinical course during hospitalization was described by using a multistate model with four states: (1) hospitalized with no cardiovascular complications; (2) hospitalized with cardiovascular complications; (3) discharged alive; (4) and dead. Cox proportional hazards regression was used to analyze the impact of prior comorbid conditions on transitions between these states. Hazard ratios (HRs) and 95% CIs are reported. RESULTS: Cardiovascular complications occurred in 18% of patients hospitalized with SARS-CoV-2 CAP. The mortality rate in this group was 45% vs 13% in patients without cardiovascular complications. Male subjects (HR, 1.32; 95% CI, 1.03-1.68), older adults (HR, 1.34; 95% CI, 1.03-1.75), and patients with congestive heart failure (HR, 1.59; 95% CI, 1.18-2.15), coronary artery disease (HR, 1.34; 95% CI, 1.00-1.79), atrial fibrillation (HR, 1.43; 95% CI, 1.06-1.95), direct admissions to the ICU (HR, 1.77; 95% CI, 1.36-2.32), and Pao2/Fio2 < 200 (HR, 1.46; 95% CI, 1.11-1.92) were more likely to develop cardiovascular complications following hospitalization for SARS-CoV-2 CAP; however, these factors are not associated with increased risk of death following a cardiovascular complication. INTERPRETATION: Prior comorbidities, older age, male sex, severity of illness, and hypoxemia are associated with increased risk of cardiovascular complications. Once patients develop cardiovascular complications, the risk of death is extremely high. Cardiovascular complications are the primary drivers of mortality in hospitalized patients with SARS-CoV-2 CAP.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ali, Sheikh, Chandler, et al. Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia. Chest. 2022. PMID: 36410493. doi:10.1016/j.chest.2022.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。